1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,264 | 0,316 | 18.05. |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 30.04. | RECCE PHARMACEUTICALS LTD: Quarterly Activities/Appendix 4C Cash Flow Report | 5 | ASX | ||
| 21.04. | RECCE PHARMACEUTICALS LTD: Positive Regulatory Inspection Outcome for Phase 3 Trial | - | ASX | ||
| 15.04. | RECCE PHARMACEUTICALS LTD: Notification of cessation of securities - RCE | 13 | ASX | ||
| 14.04. | No more tears as Recce takes on antibiotic superbug crisis | 4 | Stockhead | ||
| 24.03. | Recce Pharmaceuticals Secures Brazilian Patent for Anti-Infectives | 1 | Finance News Network | ||
| 24.03. | RECCE PHARMACEUTICALS LTD: Brazil Patent Granted for RECCE Anti-Infectives | - | ASX | ||
| 19.03. | RECCE PHARMACEUTICALS LTD: RCE Investor Webinar Presentation Deck | 13 | ASX | ||
| 17.03. | RECCE PHARMACEUTICALS LTD: RCE Investor Webinar Presentation | 2 | ASX | ||
| RECCE PHARMACEUTICALS Aktie jetzt für 0€ handeln | |||||
| 14.03. | STARK und Six Robotics kooperieren bei Recce-Strike-Fähigkeiten: Das Berliner Defence-Tech-Unternehmen ... | 14 | ES&T | ||
| 12.03. | Stark und Six Robotics starten Recce-Strike-Partnerschaft | 1 | Militär Aktuell | ||
| 12.03. | STARK und Six Robotics kooperieren bei der Bereitstellung von Recce-Strike-Fähigkeiten | 1 | hartpunkt | ||
| 27.02. | RECCE PHARMACEUTICALS LTD: Appendix 4D and Interim Financial Report | 10 | ASX | ||
| 25.02. | Polnische WB GROUP zeigt Recce-Strike-Verbund | 13 | hartpunkt | ||
| 24.02. | RECCE PHARMACEUTICALS LTD: Change of Director's Interest Notices (x5) | 2 | ASX | ||
| 24.02. | RECCE PHARMACEUTICALS LTD: Notification of cessation of securities - RCE | 1 | ASX | ||
| 03.02. | Recce Pharmaceuticals - Recce expands US government collaborations | 423 | Edison Investment Research | Recce announced that it signed a second Cooperative Research and Development Agreement (CRADA) with the US Army. This new arrangement with the US Army Institute of Surgical Research (USAISR) will study... ► Artikel lesen | |
| 01.02. | RECCE PHARMACEUTICALS LTD: Recce Enters Second U.S. Department of Defense R&D Agreement | 8 | ASX | ||
| 30.01. | RECCE PHARMACEUTICALS LTD: Quarterly Activities/Appendix 4C Cash Flow Report | 3 | ASX | ||
| 14.01. | Recce Pharmaceuticals Receives $5.3 Million R&D Rebate | 2 | Finance News Network | ||
| 14.01. | RECCE PHARMACEUTICALS LTD: AUD $5.3m R&D Rebate Received | 1 | ASX |
1 2 Weiter >>
35 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| CG ONCOLOGY | 62,93 | 0,00 % | CG Oncology Inc.: CG Oncology Reports Positive First Results from CORE-008 Cohort CX Phase 2 Trial Evaluating Intravesical Combination Therapy in High-Risk BCG-Exposed and BCG-Unresponsive Patients | - High CR rates at any time observed in the CIS-containing population with 85.7% and 92.3% in the ITT population and Efficacy Evaluable population, respectively - High-Grade - EFS in the overall intention-to-treat... ► Artikel lesen | |
| QIAGEN | 28,600 | +0,47 % | Qiagen erhöht Dividende und stellt weitere Aktienrückkäufe in Aussicht | DJ Qiagen erhöht Dividende und stellt weitere Aktienrückkäufe in Aussicht
DOW JONES--Die Aktionäre von Qiagen können sich über eine höhere Dividende freuen. Wie es in der Einladung zur Hauptversammlung... ► Artikel lesen | |
| GEOVAX LABS | 2,220 | +0,45 % | EQS-News: GeoVax, Inc.: GeoVax Highlights Strategic Importance of Domestic MVA-Based Preparedness Infrastructure Amid Escalating Global Infectious Disease Threats | EQS-News: GeoVax, Inc.
/ Key word(s): Science
GeoVax Highlights Strategic Importance of Domestic MVA-Based Preparedness Infrastructure Amid Escalating Global Infectious Disease... ► Artikel lesen | |
| BEAM THERAPEUTICS | 26,810 | 0,00 % | Beam Therapeutics presents AATD gene therapy trial data at ATS | ||
| ERASCA | 10,270 | 0,00 % | Mizuho cuts Erasca stock price target on acquisition payment | ||
| PRAXIS PRECISION MEDICINES | 320,87 | +0,11 % | Praxis Precision Medicines, Inc. - 8-K, Current Report | ||
| DESIGN THERAPEUTICS | 10,700 | 0,00 % | Design Therapeutics, Inc.: Design Therapeutics Announces Four-Week IV Data from the RESTORE-FA Trial of DT-216P2 Demonstrating Clinical Improvements and Comprehensive Biomarker Activity in Friedreich Ataxia | DT-216P2 demonstrated dose-dependent improvement in multiple clinical measures and increases in endogenous frataxin mRNA and protein after four weeks of intravenous dosing DT-216P2 generally well-tolerated... ► Artikel lesen | |
| SUMMIT THERAPEUTICS | 16,010 | -0,06 % | H.C. Wainwright Reduced its Price Goal on Summit Therapeutics Inc. (SMMT) | ||
| TANGO THERAPEUTICS | 20,660 | +0,15 % | Tango Therapeutics, Inc.: Tango Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Highlights | First clinical data from PRMT5/RAS(ON) combination trial to be presented in 2026 Cash position of $380 million as of March 31, 2026, with runway into 2028 beyond anticipated key data inflection points... ► Artikel lesen | |
| APOGEE THERAPEUTICS | 78,76 | +0,01 % | Jefferies raises Apogee Therapeutics stock price target on trial outlook | ||
| RECURSION PHARMACEUTICALS | 2,895 | +0,17 % | Recursion Pharmaceuticals (RXRX): 10 Unrivaled Penny Stocks to Buy Now | ||
| ENLIVEN THERAPEUTICS | 39,630 | 0,00 % | Enliven to present updated ELVN-001 leukemia trial data at EHA | ||
| CULLINAN THERAPEUTICS | 14,870 | 0,00 % | Cullinan Therapeutics, Inc. - 8-K, Current Report | ||
| COGENT BIOSCIENCES | 31,360 | 0,00 % | Cogent Biosciences, Inc.: Cogent Biosciences Announces Multiple Presentations at the European Hematology Association (EHA) 2026 Congress | ||
| TAYSHA GENE THERAPIES | 5,445 | 0,00 % | Canaccord Keeps Buy Rating on Taysha (TSHA) After Q1 Highlights |
Das Unternehmen RECCE PHARMACEUTICALS LTD kann der Branche Biotechnologie zugeordnet werden. Die relative Kursveränderung beträgt aktuell -3,01 % bei einem Aktienkurs von 0,258 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu RECCE PHARMACEUTICALS LTD finden Sie auf Wallstreet Online.